EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Derivatives of MOPS : promising scaffolds for SARS coronaviruses Macro domain‐targeted inhibition

Oney Ortega Granda, Karine Alvarez, Benjamin Morin, Bruno Canard, François Ferron iD, Nadia Rabah iD

The FEBS Journal · 2025

DOI: 10.1111/febs.70039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Oney Ortega Granda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille Université, CNRS, AFMB UMR 7257, Marseille, France. Hauptthemen laut MEDLINE: SARS-CoV-2, Viral Nonstructural Proteins, Antiviral Agents. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: French Infrastructure for Integrated Structural Biology, European Synchrotron Radiation Facility, Innovative Medicines Initiative 2 Joint Undertaking (JU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The severe acute respiratory syndrome coronavirus (SARS‐CoV/CoV‐2) genome encodes 16 non‐structural proteins (nsps), which coordinate cell remodeling, virus replication and participate in viral evasion. Notably, nsp3 contains a protein module termed Macro domain, which carries IFN antagonist activity that interferes with host innate immunity response. This domain is able to bind and hydrolyze ADP‐ribose derivatives. This activity is correlated to viral escape and thus makes Macro domains a valuable therapeutic target. In the present paper, we report a SARS‐CoV Macro domain structure in complex with a MOPS molecule. Based on our structural data, molecular docking was performed on a set of MOPS analogs in the ADP‐ribose binding pocket. We present an ELISA‐based assay to select hits based on the inhibition of recombinant SARS‐CoV/CoV‐2 Macro domain‐ADP‐ribose complex formation. Among the tested analogs, MOPSO and CAPSO are the more efficient in inhibiting ADP‐ribose‐binding. Structural analysis of these molecules in the ADP‐ribose pocket reveals potential interactions with amino acid residues involved in the coordination of ADP‐ribose. Overall, these findings suggest that MOPSO and CAPSO bear potential to be used as a scaffold for the design of Macro domain‐specific inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Viral Nonstructural ProteinsAntiviral AgentsHumansMolecular Docking SimulationAdenosine Diphosphate RiboseProtein DomainsBinding SitesProtein BindingCOVID-19COVID-19 Drug Treatment

Stichwörter der Autor:innen

ELISA‐like screeningMOPS analogsSARS‐CoV/CoV‐2macro domaintherapeutic target

Substanzen

Adenosine Diphosphate RiboseViral Nonstructural ProteinsAntiviral Agents

Autor:innen und Institutionen

  • Aix Marseille Université, CNRS, AFMB UMR 7257, Marseille, France.
  • European Virus Bioinformatics Center, Jena, Germany.

ORCID-Profile: François Ferron, Nadia Rabah

Förderung

  • French Infrastructure for Integrated Structural Biology
  • European Synchrotron Radiation Facility
  • Innovative Medicines Initiative 2 Joint Undertaking (JU)
  • Initiative d'Excellence d'Aix-Marseille Université

Zitieren

APA

Ortega Granda, O., Alvarez, K., Morin, B., Canard, B., Ferron, F., & Rabah, N. (2025). Derivatives of MOPS : promising scaffolds for SARS coronaviruses Macro domain‐targeted inhibition. The FEBS Journal. https://doi.org/10.1111/febs.70039

Vancouver

Ortega Granda O, Alvarez K, Morin B, Canard B, Ferron F, Rabah N. Derivatives of MOPS : promising scaffolds for SARS coronaviruses Macro domain‐targeted inhibition. The FEBS Journal. 2025. doi:10.1111/febs.70039

BibTeX
@article{OrtegaGranda2025,
  author = {Ortega Granda, Oney and Alvarez, Karine and Morin, Benjamin and Canard, Bruno and Ferron, François and Rabah, Nadia},
  title = {Derivatives of MOPS : promising scaffolds for SARS coronaviruses Macro domain‐targeted inhibition},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70039}
}
Kostenlos starten →